These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16728900)

  • 1. Sublingual immunotherapy for allergic rhinitis: an update.
    Burastero SE
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):197-201. PubMed ID: 16728900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
    Campbell DE
    Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of sublingual immunotherapy.
    Scadding G; Durham S
    J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety.
    Kariyawasam HK; Rotiroti G; Robinson DS
    Rhinology; 2013 Mar; 51(1):9-17. PubMed ID: 23441306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
    Cox L; Wallace D
    Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New visions in specific immunotherapy in children: an iPAC summary and future trends.
    Halken S; Lau S; Valovirta E
    Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic rhinitis.
    Kemp AS
    Paediatr Respir Rev; 2009 Jun; 10(2):63-8. PubMed ID: 19410204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short review on sublingual immunotherapy for patients with allergic rhinitis: from bench to bedside.
    Kawauchi H; Goda K; Tongu M; Yamada T; Aoi N; Morikura I; Fuchiwaki T
    Adv Otorhinolaryngol; 2011; 72():103-6. PubMed ID: 21865703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative medicine for allergic rhinitis.
    Man LX
    Curr Opin Otolaryngol Head Neck Surg; 2009 Jun; 17(3):226-31. PubMed ID: 19262383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating allergic rhinitis: continuous versus on-demand regime? Executive summary of the Supportive Initiatives for the Global Management of Allergy (SIGMA): report from the Belgian Working Group.
    Church MK; Watelet JB;
    B-ENT; 2009; 5 Suppl 12():1-25. PubMed ID: 19475789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic rhinitis.
    Mims JW
    Facial Plast Surg Clin North Am; 2012 Feb; 20(1):11-20. PubMed ID: 22099613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undertreatment of allergy: exploring the utility of sublingual immunotherapy.
    Emanuel IA; Parker MJ; Traub O
    Otolaryngol Head Neck Surg; 2009 May; 140(5):615-21. PubMed ID: 19393398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life outcomes with sublingual immunotherapy.
    Wise SK; Woody J; Koepp S; Schlosser RJ
    Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy: where do we stand? Present and future.
    Passalacqua G; Pawankar R; Baena-Cagnani CE; Canonica GW
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):1-3. PubMed ID: 19106697
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules.
    Passali D; Mösges R; Passali GC; Passali FM; Ayoko G; Bellussi L
    Acta Otorhinolaryngol Ital; 2010 Jun; 30(3):131-7. PubMed ID: 20948588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.